School of Medicine


Showing 51-100 of 136 Results

  • Dora Ho

    Dora Ho

    Clinical Professor, Medicine - Infectious Diseases

    Current Research and Scholarly InterestsDr. Ho did her PhD work in HSV pathogenesis and postdoctoral research in CNS gene therapy with viral vectors. She is currently the clinical chief of the Division of Infectious Diseases and Geographic Medicine. She specializes in infection complications of immunocompromised patients, such as those with cancers, solid organ transplant or bone marrow transplant.

  • Seth Ari Sim-Son Hoffman

    Seth Ari Sim-Son Hoffman

    Postdoctoral Medical Fellow, Infectious Diseases
    Fellow in Medicine

    Current Research and Scholarly InterestsClinical research to benefit underserved populations.

  • Mark Holodniy

    Mark Holodniy

    Professor of Medicine (Infectious Diseases)

    Current Research and Scholarly InterestsMy research program is currently focused in three areas: 1) Translational research (viral evolution and antiviral resistance prevalence and development), 2) Clinical trials (diagnostic assay/medical device, antimicrobials and immunomodulators), and 3) Health services research focusing on public health, infectious diseases and clinical outcomes.

  • Marisa Holubar

    Marisa Holubar

    Clinical Associate Professor, Medicine - Infectious Diseases

    BioDr. Marisa Holubar specializes in the treatment of infectious diseases and works primarily in the inpatient setting. She is particularly interested in antimicrobial stewardship.

  • Prasanna Jagannathan

    Prasanna Jagannathan

    Assistant Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology

    BioI am an Infectious Diseases physician-scientist with a research program in human immunology of malaria and clinical trials of immune modulatory interventions. Our group has been conducting detailed longitudinal cohort studies in children and pregnant women in order to study how repeated malaria shapes the cellular immune response. We are also studying how malaria control interventions such as antimalarial chemoprevention and vector control shape the acquisition and/or maintenance of protective immunity to malaria. We have expanded this work to not only include studying the mechanisms driving naturally acquired immunity to malaria, but other infectious diseases, including SARS CoV-2. We have also lead and/or participated in studies evaluating therapeutic strategies for patients with mild to moderate COVID-19.

  • Shanthi Kappagoda

    Shanthi Kappagoda

    Clinical Associate Professor, Medicine - Infectious Diseases

    Current Research and Scholarly InterestsCompleted a Masters degree in Health Services Research in 2012. Research focused on using network models to develop a clinical research agenda for neglected tropical diseases.

  • Abraar Karan, MD MPH DTM&H

    Abraar Karan, MD MPH DTM&H

    Postdoctoral Medical Fellow, Infectious Diseases
    Masters Student in Epidemiology and Clinical Research, admitted Autumn 2022
    Fellow in Medicine

    BioI am an infectious disease fellow and post-doctoral researcher in the Division of Infectious Diseases and Geographic Medicine, the Luby Lab, the Center for Innovation in Global Health, and the Woods Institute for the Environment. I worked on the Covid19 outbreak for the Massachusetts Department of Public Health in 2020, and the Monkeypox outbreak for the Los Angeles County Department of Public Health in 2022-23. I also served on the WHO-commissioned Independent Panel on Pandemic Preparedness and Response's research team investigating early global spread of Covid19, and helped with policy-writing for the Biden-Harris campaign on reducing Covid19 in schools. I am currently the Principal Investigator of the following studies: a cluster-randomized controlled trial investigating whether air filtration and ventilation can reduce spread of Covid19 in low-income homes in the Bay Area (https://clinicaltrials.gov/ct2/show/NCT05777720); piloting a low-cost rural surveillance system for detecting spillover of zoonotic diseases in Western Kenya.

    I completed my internal medicine residency at the Brigham and Women's Hospital/Harvard Medical School in the Global Health Equity program, and have been working in global health since 2008. I co-edited the book, "Protecting the Health of the Poor" (December 2015, Bloomsbury Publishing, https://www.bloomsbury.com/us/protecting-the-health-of-the-poor-9781783605521/); and co-founded Longsleeve insect repellent, winner of the 2018 Harvard Business School New Venture Competition and finalist in the 2019 Harvard President's Challenge. Media/press coverage has included NBC, ABC, BBC, PBS, CBS, CNN, MSNBC, Fox News, Washington Post, New York Times, SF Chronicle, Bloomberg, Boston Globe, ProPublica, WSJ, TIME, Politico, CBC News, Democracy Now, NPR, ESPN, The Atlantic, The Hill, Business Insider, Vice, Mother Jones, Vox, Forbes, Slate, STAT News, MTV News, Mother Jones, Science Friday, TMZ.

    For a full list of publications, please see "Publications" tab. For full list of press/media interviews, please see "Media" link.

  • Melanie Ann Kiener

    Melanie Ann Kiener

    Postdoctoral Medical Fellow, Infectious Diseases
    Fellow in Medicine

    BioI am an adult infectious disease fellow completing my post-doctoral research years in Dr. Desiree LaBeaud's lab. My research interests include global health epidemiology, infectious diseases diagnostics and global antimicrobial stewardship.

  • Michael Kozal

    Michael Kozal

    Senior Associate Dean for Veterans Affairs and Professor of Medicine (Infectious Diseases)

    BioDr. Kozal was appointed Senior Associate Dean for Veteran Affairs at Stanford School of Medicine and Chief of Staff at VA Palo Alto Health Care System in 2021. Prior to coming to Stanford, he served as Associate Dean for Veteran Affairs at Yale University School of Medicine and the Chief of Staff at VA Connecticut Healthcare System.

    Dr. Kozal is a translational researcher who has focused his research career on three areas: 1) investigating the genetic determinants of HIV and HCV drug resistance, 2) the development of new molecular methods to detect viral mutations, and 3) HIV and HCV clinical trials involving new drugs and diagnostic technology. Dr. Kozal is an expert in microarray and deep sequencing technology receiving patents for his work in genotyping. Dr. Kozal previously directed the Yale HIV Clinical Trials Group and has more than 20 years of experience in running clinical trials, serving as the principal investigator or site investigator on >40 HIV and Hepatitis C trials. He has served on multiple VA and NIH/NCI review panels and is a current a member of the DHHS/NIH Panel on Antiretroviral Guidelines for Adults and Adolescents.

  • Max Lamparth

    Max Lamparth

    Postdoctoral Scholar, Infectious Diseases

    BioMax is a postdoctoral fellow at the Center for International Security and Cooperation, the Stanford Center for AI Safety, and the Stanford Existential Risks Initiative at Stanford University. I am advised by Prof. Clark Barrett, Prof. Steve Luby, and Prof. Paul Edwards.

    With his research, he wants to make AI systems more secure and safe to use. Specifically, he is focussing on how to improve the robustness and alignment of language models, how to make their inner workings more interpretable, and how to reduce the potential for misuses.

    He received his Ph.D. in August 2023 from the Physics Department at the Technical University of Munich and previously a B.Sc. and M.Sc. from the Ruprecht Karl University of Heidelberg.

  • Vivian Levy

    Vivian Levy

    Clinical Associate Professor (Affiliated), Medicine - Med/Infectious Diseases
    Staff, Medicine - Med/Infectious Diseases

    BioVivian Levy is Chief of Infectious Diseases at San Mateo Medical Center (SMMC), San Mateo County’s safety net hospital and clinic system in northern California since 2015 and the County’s STD Control Officer since 2006. San Mateo County has 760,000 persons and connects the urban centers of San Francisco and San Jose, California.
    Dr. Levy leads Stanford’s Internal Medicine outpatient Infectious Diseases rotation for Internal Medicine residents. She has served 2 terms as president of the California STD/HIV Controllers Association. From 2004-2008, she was the medical officer for the Chemoprophylaxis for HIV prevention in men study in Lima, Peru.
    In 2020, she was the San Mateo Medical Center site investigator for the Expanded Access Treatment Protocol: Remdesivir for the Treatment of SARS-CoV2 Infection. She began SMMC patient recruitment for Stanford outpatient COVID studies July 2020 with the goal of increasing historically underrepresented populations participation and access in COVID outpatient treatment trials.
    She has an undergraduate degree from Brown University (1989,) an MD from Rush University Medical College in Chicago (1994,) completed internship in Internal Medicine at Cook County Hospital in Chicago (1995) Internal Medicine residency at Northwestern University (1997) and an Infectious Diseases and Geographic Medicine fellowship at Stanford University (2000-2004.)

  • Anne Liu

    Anne Liu

    Clinical Associate Professor, Pediatrics - Immunology and Allergy
    Clinical Associate Professor, Medicine - Infectious Diseases
    Clinical Associate Professor (By courtesy), Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Liu is a board-certified, fellowship-trained specialist in allergy/immunology and infectious disease. She is also a clinical associate professor in the Department of Medicine, Division of Infectious Diseases and the Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology at Stanford University School of Medicine.

    Dr. Liu treats infections in patients with compromised immune systems, whether due to a primary immune deficiency or a condition like cancer or organ transplant. She helps patients to develop tolerance to medications they are allergic to so that they can receive the best, and sometimes the only, treatments available to them. She also treats allergies to antibiotics, aspirin, NSAIDs, chemotherapy, and more. She sees patients both long term and for urgent referrals, such as in cases of perioperative anaphylaxis. Dr. Liu also helps pediatric patients manage drug and food allergies.

    One of Dr. Liu’s areas of focus is helping patients with allergies to antibiotics determine when they have lost an allergy, what antibiotics they can tolerate, and when to induce tolerance to an antibiotic. This not only can benefit the patient, but also have a positive public health impact, as labeling patients with a penicillin allergy may negatively affect their care and increase use
    of broad-spectrum antibiotics.

    She collaborates closely with colleagues from other disciplines, including pulmonology, otolaryngology, oncology, cardiology, dermatology, anesthesiology, and surgery. Her key objective in working with referring physicians is to help them safely deliver the best care for their patients.

    For patients and families, Dr. Liu strives to help them navigate their care journey with as much ease and dignity as possible during what may be the most challenging time of their life. Her goal is to offer patients options, even when it may appear that they have no options left.

    Dr. Liu’s research interests include optimizing care of patients with antibiotic allergies, including through use of decision support tools.

    Dr. Liu has authored articles in the New England Journal of Medicine, Journal of Immunology, Journal of Allergy and Clinical Immunology in Practice, Clinical and Experimental Allergy, Mucosal Immunology, Diagnostic Microbiology and Infectious Disease, Science, and other publications. Dr. Liu authored the book chapter “Hypersensitivity Reactions to Monoclonal Antibodies” in Drug Allergy Testing.

    Dr. Liu is certified in infectious disease by the American Board of Internal Medicine and in allergy and immunology by the American Board of Allergy and Immunology. She is also a member of the American College of Physicians, Infectious Diseases Society of America, and American Academy of Allergy, Asthma, and Immunology.

    She has given presentations on antibiotic allergies, drug desensitization, and aspirin-exacerbated respiratory disease, among other topics. Dr. Liu’s honors include recognition from the American Academy of Asthma, Allergy, and Immunology, the American Medical Women’s Association, and the National Institutes of Health.

  • Nathan Lo

    Nathan Lo

    Assistant Professor of Medicine (Infectious Diseases)

    Current Research and Scholarly InterestsOur research laboratory is interested in studying the transmission of infectious diseases and impact of public health strategies with an ultimate goal of informing public health policy. Our group applies diverse computational methodologies, including tools of epidemiology, modeling, pathogen genomics, and policy analysis. We study a diverse set of pathogens including neglected tropical diseases, vaccine-preventable infections, and COVID-19.

    A large emphasis of our work is translating scientific evidence into public health policy. Our track record includes multiple studies that have changed policy in the fields of neglected tropical diseases and COVID-19. We work closely with policy organizations like the World Health Organization and the California Department of Public Health.

    Our current research focuses on the following areas:
    (1) Vaccine-preventable infectious diseases in the United States
    (2) Public health strategies for tropical infections, such as helminths infections (schistosomiasis) and typhoid fever
    (3) Public health strategies to control the COVID-19 pandemic

    Hiring
    We are seeking to fill multiple research positions at all levels. Candidates interested in working on computational public health research related to infectious diseases with a strong quantitative background are highly encouraged to apply. If you an interested, please submit a cover letter, CV, and names of two references to Nathan.Lo@stanford.edu.

  • Stephen Luby

    Stephen Luby

    Lucy Becker Professor of Medicine, Senior Fellow at the Woods Institute for the Environment, Freeman Spogli Institute for International Studies and Professor, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsDr. Luby’s research interests include identifying and interrupting pathways of infectious disease transmission in low income countries.

  • Natalia Medvedeva

    Natalia Medvedeva

    Clinical Assistant Professor, Medicine - Infectious Diseases

    BioDr Natalia Medvedeva specializes in the treatment of infectious diseases. She has a special interest in antimicrobial stewardship and medical education.

  • Thomas Charles Merigan M.D.

    Thomas Charles Merigan M.D.

    George E. and Lucy Becker Professor of Medicine, Emeritus

    Current Research and Scholarly InterestsI am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.

  • Joanna Nelson

    Joanna Nelson

    Clinical Assistant Professor, Medicine - Infectious Diseases

    BioDr. Nelson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have had solid organ or bone marrow transplantation or who have malignancy undergoing chemotherapy. She also has a special interest in caring for patients with Cystic fibrosis or who have had a lung transplant as well as Nontuberculous mycobacterial Infections.

  • Andrew Nevins

    Andrew Nevins

    Clinical Professor, Medicine - Infectious Diseases

    Current Research and Scholarly InterestsClinical general infectious diseases. Medical education.

  • Julie Parsonnet

    Julie Parsonnet

    George DeForest Barnett Professor of Medicine and Professor of Epidemiology and Population Health

    Current Research and Scholarly InterestsI am an infectious diseases epidemiologist who has done large field studies in both the US and developing countries. We research the long-term consequences of chronic interactions between the human host and the microbial world. My lab has done fundamental work establishing the role of H. pylori in causing disease and understanding its epidemiology. Currently, our research dissects how and when children first encounter microbes and the long term effects of these exposures on health.

  • Ruoxi Pi

    Ruoxi Pi

    Postdoctoral Scholar, Infectious Diseases

    BioI received my BS in Biological Sciences in Zhejiang University in China, where I conducted research in polyphasic taxonomy in anaerobic bacteria. I received my PhD in Yale University, where I studied the early events of retrovirus infection in animal models. Now in the Blish lab, I am investigating NK cell responses during HIV-1 infection and trying to manipulate the NK cells to target latently infected cells.

  • Benjamin Pinsky

    Benjamin Pinsky

    Professor of Pathology, of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases)

    Current Research and Scholarly InterestsDevelopment and application of molecular assays for the diagnosis and management of infectious diseases.

  • Orlando Quintero, MD

    Orlando Quintero, MD

    Clinical Assistant Professor, Medicine - Infectious Diseases

    BioDr. Orlando Quintero is a board-certified, fellowship trained internist specializing in the diagnosis and treatment of infectious diseases. He is also clinical assistant professor in the Department of Medicine, Division of Infectious Diseases, at Stanford University School of Medicine.

    As a clinician, Dr. Quintero diagnoses and treats infectious diseases in immunocompromised patients. This includes the prevention, diagnosis and treatment of infections in patients who are immunosuppressed because of Solid Organ Transplantation, Bone Marrow (Hematopoeitic Cell) Transplants, Hematologic Malignancies, Chemotherapy for Solid Tumors, HIV who receive Chemotherapy, Solid Organ or Bone Marrow Transplants Immunomodulators for Auto-Immune Diseases and other forms of immunodeficiency.

    Dr. Quintero has published on topics including coronavirus in kidney transplant patients, prevention of cytomegalovirus in heart transplant patients, and prevention of urinary tract infections in renal transplant patients. His work has appeared in publications including Transplant Infectious Disease, Emerging Infectious Diseases, and the Journal of Heart and Lung Transplantation.

    He has delivered presentations at meetings of organizations including the International Society for Heart and Lung Transplantation, Interscience Conference on Antimicrobial Agents and Chemotherapy, and American Society of Tropical Medicine and Hygiene. Topics of his presentations have included prevention of cytomegalovirus, prevention of recurrent urinary tract infections, Chagas disease in New York City, and more.

    Currently, Dr. Quintero is conducting research on treatment of patients with COVID-19, prevention and treatment of invasive fungal infections of the gastrointestinal tract in immunocompromised patients, and the epidemiology of invasive fungal infections in heart transplant recipients.

    Among his awards, He has received honors for his teaching and research from Albert Einstein College. He also has earned recognition from the Fred Hutchinson Cancer Research Center and the American Society of Transplantation.

    Dr. Quintero’s volunteer community service includes participation in health fairs to promote HIV testing and hypertension control, plus disease management in the Garifuna population in New York – descendants of an Afro-indigenous population from the Caribbean island of St. Vincent.

    He is a member of the Infectious Disease Society of American, Infectious Diseases Association of California, American Society of Transplantation, and HIV Medicine Association.

  • David A. Relman

    David A. Relman

    Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology
    On Leave from 01/15/2024 To 12/20/2024

    Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.

  • Cybele A. Renault, MD, DTM&H, FIDSA

    Cybele A. Renault, MD, DTM&H, FIDSA

    Clinical Associate Professor, Medicine - Infectious Diseases

    BioDr. Renault has devoted her career to caring for vulnerable patient populations, both domestically and overseas. She completed her medical school and residency training at the University of Chicago, caring for underserved patients on Chicago's South Side, followed by a Chief Resident year at John H. Stroger, Jr. Hospital of Cook County, the public hospital serving the uninsured in Chicago. She began her career in global health as an Infectious Diseases fellow at Stanford, validating low-cost HIV diagnostics in Burkina Faso, and providing clinical service and teaching in India and Zimbabwe as a fellow, and later in Thailand, Uganda, Rwanda and Kenya as one of our Infectious Diseases faculty. Her clinical work is focused on caring for our veteran population, working to empower veterans to engage in their care, often in the setting of significant mental illness.

    Dr. Renault is most passionate about medical education and program development to combat global antimicrobial resistance through antimicrobial stewardship, to create opportunities for the Internal Medicine residents centering on caring for vulnerable patient populations, and to develop impactful and sustainable programs in collaboration with our low- and middle-income partners for our Center for Innovation in Global Health. She served as Associate Program Director for the Internal Medicine Residency Program for 4 years prior to transitioning to her current role as Program Lead for Global Health, for which she leads the Global Health Track for the Internal Medicine residency program and develops global health initiatives for the Department of Medicine. She co-founded and has been director of the Stanford 2-week intensive global health course since its inception in 2012, she has structured trainee and faculty rotations based on evolving needs of our partner sites in Uganda, Rwanda, Zimbabwe and Sri Lanka, she is the faculty lead for the ID/antimicrobial stewardship partnership between Stanford and Moi Teaching and Referral Hospital in Eldoret, Kenya, and she is leading Stanford's Internal Medicine virtual case-based education initiative to support our newest medical school partner in Negele Arsi, Ethiopia.

    Dr. Renault strives to augment Stanford's contributions and support for underserved patient populations in the United States. She established resident rotations in Shiprock, New Mexico and Chinle, Arizona through the Indian Health Service, and she is Faculty Advisor for the Internal Medicine Health Equity, Advocacy and Research concentration in the residency program. She also aspires to improve resources for women physicians. In 2016, Dr. Renault established the GME Women in Medicine Leadership Council, with the intention of creating community and encouraging conversations about professional and personal life decisions as women in the field of medicine. She is passionate about mentoring through sharing personal experiences, creating an environment that encourages reflection, and building skills to address challenges unique to women in medicine.

    In 2022, in recognition of her passion for medical education and her success in program development, Dr. Renault was asked to join the leadership at Palo Alto Veterans Health Care System as Deputy Associate Chief of Staff for Education. In this role, she works with rotation directors to optimize their respective rotations to offer robust educational opportunities for trainees across specialties who are rotating at the Palo Alto VA.

  • Izabela Mauricio Rezende

    Izabela Mauricio Rezende

    Postdoctoral Scholar, Infectious Diseases

    BioI have a B.S. in Biology, M.Sc. in Immunology and Infectious diseases, Ph.D. in Microbiology. I am currently a Postdoctoral Researcher at the Stanford University School of Medicine, working with Dr. Jason Andrews at the new Stanford Pandemic Preparedness Hub, a fellowship I was awarded at the end of 2022. As part of a pandemic preparedness, We are tytrying to understand the potential viruses at risk of pandemic spread. Using disease modeling, epidemiological, and phylogenetic analysis, we study the genomic evolution and transmission dynamics of H5N1 avian influenza A after 2020.

    I am in my third postdoctoral year at Stanford and completed the first two years with Dr. Desiree LaBeaud. I have a Ph.D. in Microbiology, with an emphasis in Virology, and a Master’s in Infectious Diseases. . My Ph.D. was conducted in Brazil, under the supervision of Dr. Betânia Drumond, and contemplated the virological and epidemiological aspects of yellow fever (YF) outbreak in Minas Gerais/BR in 2017-2018, combining laboratory, clinical, and data analysis (publications: DOI 10.1126/science.aat7115; DOI 10.1371/journal.pntd.0006538; DOI 10.1128/jcm.00254-22; DOI 10.3390/vaccines7040206; DOI 10.1186/s12985-019-1277-7). I came to Stanford University for my first postdoc with Dr. Desiree LaBeaud. For two years, I led an international NIH R01 project investigating the dynamics of the biggest YF outbreak in Brazil, including the description of a new syndrome, Late-relapsing hepatitis after yellow fever (DOI 10.3390/v12020222), and risk factors for severe YF. I was also involved in other projects regarding SARS-CoV-2 variants and disease severity in infants (DOI 10.3389/fmed.2022.896352), Rift Valley fever virus epidemiology in humans and animals in Kenya (DOI 10.1371/journal.pgph.0000505), and dengue virus evolution in Africa (ongoing Ph.D. candidate mentorship).

    During the COVID-19 pandemic, we also supported the Brazilian Ministry of Health with the SARS-CoV-2 diagnosis in human samples and also in the investigation of the SARS-CoV-2 RNA in surfaces of density public areas of Belo Horizonte. Since Nov/2018 I had been an editor in the journal Docência do Ensino Superior (RDES / GIZ / UFMG) and in Jan/2020 I became Editor-in-Chief.

  • Arjun Rustagi, MD, PhD

    Arjun Rustagi, MD, PhD

    Instructor, Medicine - Infectious Diseases

    BioDr. Arjun Rustagi is an Instructor in Medicine. He is a graduate of the University of Washington Medical Scientist Training Program and Stanford's Internal Medicine Residency and Infectious Diseases Fellowship.
    He is dedicated to understanding the early immune responses to infections, and the methods pathogens use to persist despite these responses, in order to inform new prevention and treatment strategies. He studies viral pathogenesis and immunity with Dr. Catherine Blish, under whose mentorship he set up the respiratory viral biosafety level 3 (BSL3) program at Stanford in early 2020 in order to study SARS-CoV-2, contributing to several projects in SARS-CoV-2 virology including a study of intact in vitro lung tissue infection. He also protocoled the first peripheral immune profiling study of severe COVID-19. His ongoing interest is in the full spectrum of in vitro respiratory viral models, particularly those that recapitulate lung epithelium and mucosal immunity.